Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Summary

Since the introduction of antiretroviral therapy life expectancy of HIV-infected persons is rising. Different cohorts are observing an increased risk for cardiovascular diseases in this aging HIV-infected population. Traditional cardiovascular risk factors like smoking are more frequent in HIV-infected persons. For example chronic inflammation due to HIV-infection and metabolic disorders also caused by some antiretroviral substances as special non-traditional risk factors in HIV-infected persons can influence the development of cardiovascular diseases additionally. Therefore new research focus in special risk profile associated with HIV-infection or antiretroviral treatment and prevention for HIV-infected patients is developing.

This present study is an ongoing prospective regional multicenter trial that was conducted to analyse the incidence, prevalence and clinical course of cardiovacular disorders in HIV-infected out-patients.

Cardiac disorders witch are associated with HIV are pericarditis, pleural effusion, pulmonary hypertension, dilated cardiomyopathy, heart failure, myocarditis, bacterial endocarditis and heart valve disorders. In addition to previously stated disorders of the heart, the premature atherosclerosis of coronary arteries, a further even more important disease of the heart in this patient population, went into the focus of most HIV-researchers and physicians.

Conditions

• Coronary Heart Disease
• Heart Failure
• HIV
• AIDS
• Metabolic Syndrome

Interventions

OTHER

Comprehensive non invasive cardiovascular examination

* Anamnesis with the participian * File recherche,Physical examination * Documentation of the carciovascular and antiretroviral medical therapy * Electrocardiogram * Transthoracic echocardiography * Exercise electrocardiogram * Measuring of the arterial media thickness * Exercise Montreal Cognitive Assesment test * Exercise the Grooved Pegboard test * Blood collection * Questionnaire to quality of life and health economics

Sponsors & Collaborators

• HIV-HEART Study Investigative Group

  collaborator UNKNOWN

• German Heart Failure Network

  collaborator OTHER

• German Federal Ministry of Education and Research

  collaborator OTHER_GOV

• Bristol-Myers Squibb

  collaborator INDUSTRY

• ViiV Healthcare

  collaborator INDUSTRY

• Gilead Sciences

  collaborator INDUSTRY

• Janssen-Cilag GmbH

  collaborator UNKNOWN

• Abbott

  collaborator INDUSTRY

• Boehringer Ingelheim

  collaborator INDUSTRY

• Merck Sharp & Dohme LLC

  collaborator INDUSTRY

• University Hospital, Essen

  lead OTHER

Principal Investigators

• Stefan Esser, MD · University Hospital, Essen

• Till Neumann Neumann, MD · University Hospital, Essen

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2012-04-30

Primary Completion

2014-04-30

Completion

2014-10-31

Countries

• Germany

Study Locations